STEPHANIE PENNIE: Open Payments
NPI 1255976643 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 49 payments from 9 companies in 2025. Trend: 2023 $652 · 2024 $655 · 2025 $1,110
Food & beverage: $1,102Education: $8
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $315 |
| GlaxoSmithKline, LLC. | 5 | $208 |
| ABBVIE INC. | 12 | $171 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $117 |
| UCB, Inc. | 3 | $88 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Janssen Biotech, Inc. | 3 | $47 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
Products named: BENLYSTA, KRYSTEXXA, RINVOQ, Bimzelx, COSENTYX, SKYRIZI, SAPHNELO, TREMFYA.
Industry payments across OK — which companies pay providers there.
